Herpes News

Brand New Forums at HerpesDoctor!

HerpesDoctor are pleased to announce the addition of two new forums today, General Chat, for members to discuss pretty much whatever they like, and Meet & Greet, where you can hook up with other people with Herpes and make friends online.

Chickenpox Vaccine Linked with Shingles Epidemic

New research published in the International Journal of Toxicology (IJT) by Gary S. Goldman, Ph.D., reveals high rates of shingles (herpes zoster) in Americans since the government's 1995 recommendation that all children receive chicken pox vaccine. Goldman's research supports that shingles, which results in three times as many deaths and five times the number of hospitalizations as chicken pox, is suppressed naturally by occasional contact with chicken pox.

Report: Herpes Test Often Wrong

There's a fairly disturbing report being reported by Reuters that says Herpes lab tests are often wrong. According to the report published in the American Journal of Obstetrics and Gynecology more than half of 172 labs reported a sample as being positive for HSV2 (Genital Herpes), when in actual fact, it was negative, but positive for HSV1 (cold sores).

Reporting Herpes in Newborns

Neonatal herpes, infection of newborns with herpes simplex virus type 1 or type 2—the causes of genital herpes and cold sores—should routinely be reported to health authorities, say experts. In a commentary published in the September issue of the journal Sexually Transmitted Diseases, some of the nation’s leading researchers in herpes infections point out that unlike all comparable health problems in newborns, neonatal herpes is a reportable condition in only 7 states.

Blog Addresses Herpes Dating Problems in London

A blog, or weblog, which is usually a personal website posted to regularly about a specific topic, is now taking on the challenge of sexual relations and dating in London.

Herpes & Rheumatoid Arthritis

A link between Herpes and rheumatoid arthritis has been found by spanish researchers. They're not certain if the relationship with Herpes is causitive of Arthritis but believe it worth monitoring the Herpes DNA levels in Arthritis patients.

Cranberries: New Hope for Herpes Treatment

Cranberries 'could treat herpes'

Cranberries may be an effective treatment for the herpes virus, researchers claim.

The berry is known to be effective in treating bladder conditions.

I Have Herpes - Don't You?

I Have Herpes -Don't You? is the tag line for the International Herpes Week, 10 - 16 October 2004, aiming to make people aware that Herpes is one of the most common viruses in the world and that there is no need to be embarrassed about it.

Strong link found between HSV2 and HIV in sub-Saharan Africa

More evidence was presented this week by researchers from London regarding the strong link between infection with herpes simplex virus-2 (HSV-2) and the transmission of HIV, this time from an epidemiological perspective. The results of a cross-sectional study of 1000 married heterosexual couples in four cities in sub-Saharan Africa, published in the latest issue of the journal AIDS, suggest that HSV-2 is the key risk factor in promoting HIV transmission.

A Cure for Herpes - New Research Encouraging

P Vijayan and co-workers at the J S S College of Pharmacy in Ootacamund in Tamil Nadu report that extracts of Hypericum Mysorense and Hypericum Hookeranum suppressed HSV infection 100 per cent.

Rare Circumcision Ritual Carries Herpes Risk

An interesting piece in WebMD today about a rare Jewish ritual that involves the person performing the circumcision to suck the blood of the circumcised penis after performing the operation.

Herpes Simplex to Battle Brain Tumors

The BBC are reporting that Glasgow University have been granted approval for a large scale clinical trial using a modified Herpes Simplex virus to battle glioma (an aggressive type of brain tumor).

ViroPharma Initiates Maribavir Phase 2 Program In Bone Marrow Transplant Patients

EXTON, Pa., July 27, 2004 -- ViroPharma Incorporated (Nasdaq:VPHM) today announced the initiation of its Phase 2 clinical program for maribavir, an oral antiviral drug that inhibits cytomegalovirus (CMV), in allogeneic bone marrow (stem cell) transplant patients. Preliminary data from the Phase 1 maribavir program presented recently at the Company's pre-Phase 2 clinical investigator's meeting showed a favorable safety and pharmacokinetic profile for maribavir.

Valacyclovir More Effective than Acyclovir Against Herpes Zoster

In a new article about the treatment of Post Herpetic Neuralgia at The Journal Pharmacy Technology the conclusion is drawn that Valacyclovir is far more effective than Acyclovir in the treatment of Post Herpetic Neuralgia

HIV/AIDS - Suppresive Therapy for HSV2 Still Needed

As the struggle to find an answer to the problem surrounding HIV/AIDS patients and the complications that HSV2 - Genital Herpes and CMV can cause continues. Aidsmap.com report on the discovery that HAART (combination therapy) treated HIV/AIDS patients saw no significant reduction in the shedding of the HSV2 virus.

ViroPharma Announces 'Teach-In' on Cytomegalovirus Infection

EXTON, Pa., July 16, 2004 -- ViroPharma Incorporated (Nasdaq:VPHM) announced today that the company will host a 'Teach-in' on cytomegalovirus (CMV) infection at the Plaza Hotel in New York City at 5:00 P.M. Eastern Time on July 21, 2004. At the meeting, transplant physicians and members of senior management will provide an overview of CMV in the immunocompromised and transplant setting, the challenges of managing patients at risk of CMV infection, currently available treatments, the opportunities for new therapies, and an overview of maribavir, ViroPharma's leading clinical candidate molecule that inhibits CMV.

Lyrica® Gets Approval in Europe - New Drug may Combat Post Herpetic Pain

NEW YORK, July 6, 2004 -- Pfizer Inc said today that it has received approval from the European Commission to market Lyrica® (pregabalin) in all European Union member states for the treatment of peripheral neuropathic pain and as an adjunctive therapy for partial seizures in patients with epilepsy. Developed by Pfizer, Lyrica is a new compound with analgesic and anticonvulsant properties.

Herpes Treatment: Virox - New Drug to Expand Distribution in US

CARSON CITY, NV, June 14 /PRNewswire-FirstCall/ -- Sonic Media Corp. (SMED.OB) today announced broad new retail and wholesale distribution in the U.S. for Virox, a series of products designed to treat all types of herpes and other viral infections naturally through use of a plant extract derived from the desert shrub Larrea tridentata. Virox products are manufactured by LarreaRX, Inc., utilizing Virastatin(TM), a proprietary extract of the plant that is supplied exclusively by recently acquired Sonic Media subsidiary Global Botanics, Inc.

Herpes Vaccine - Could reduce Genital Herpes by 40% in next 25yrs

There is no cure for Herpes Simplex. Unfortunately it is becoming
more and more common and especially Genital Herpes (HSV2) It is estimated that 1 in 4 adults in the US
have Herpes Simplex
and it afflicts 30% more women than men.

It is
estimated that most people who get Genital Herpes acquire it in
their teenage years and early twenties. Health care expenses are estimated
to be in the region of $1 Billion yearly.

Yo-Yo Dieting - New Study shows that Immune Systems can Suffer - Increased Chance of Herpes Outbreaks

Yo-Yo dieting, in which a person repeatedly loses and regains weight, may have a lasting negative impact on immune function, according to new findings by researchers at Fred Hutchinson Cancer Research Center. Conversely, maintaining the same weight over time appears to have a positive effect on the immune system, report Cornelia Ulrich, Ph.D., and colleagues in the June issue of the Journal of the American Dietetic Association.

Syndicate content

Back to top